Surgery for rheumatic tricuspid valve disease: A 30-year experience

Slides:



Advertisements
Similar presentations
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Advertisements

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Stephen R. Broderick, MD, MPHS 
Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period  Hector Alonso-Valle, MD, PhD, Concepcion Fariñas-Álvarez,
Outcome of 200 patients after an extracardiac Fontan procedure
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
Surgical treatment of pseudoaneurysm of the thoracic aorta
Improving health care by embracing Systems Theory
Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year.
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Form ever follows function
Victor van Berkel, MD, PhD 
Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease  Vincent Chan, MD, MPH, Marc Ruel, MD,
It is still mostly about the mitral valve
How should we treat air leaks?
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Bicuspid aortic valve aortopathy: One size fits all?
A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R
Long-term results of aortic valve–sparing operations in patients with Marfan syndrome  Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.
Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation  Michael H. Kwon,
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 
Intermediate-term results of repair for aortic, neoaortic, and truncal valve insufficiency in children  John A. Hawkins, MD, Peter C. Kouretas, MD, PhD,
The variability of the mitral valve anatomy and terminology
Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement  Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Transcatheter aortic valve replacement in intermediate-risk patients
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms  Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,
Military surgeons just want to have fun
Intermediate results of isolated mitral valve replacement with a Biocor porcine valve  Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD,
Jules Lin, MD  The Journal of Thoracic and Cardiovascular Surgery 
Stephen R. Broderick, MD, MPHS 
Get it right the first time
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Minimally invasive tricuspid valve surgery in patients at high risk
Replicating the success of mitral valve repair in the aortic valve
A fate worse than death  Jennifer S. Lawton, MD 
Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry  Daniel J.P. Burns, MD, MPhil  The Journal of.
The Ross procedure: Outcomes at 20 years
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Functional tricuspid pathology: To treat or not to treat
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients  Nicolas Amabile, MD,
Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone?  Juan A. Crestanello, MD  The Journal of.
The future of cardiac surgery training: A survival guide
Aortic Carpentier-Edwards supraannular porcine bioprosthesis: a 12-year experience  Yves Logeais, MD, Thierry Langanay, MD, Alain Leguerrier, MD, Claude.
The continuing challenge of congenital heart disease in China
Commentary: When a choice is not an echo
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
“The more things change…”: The challenges ahead
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
Preoperative PFTs: The answer is blowing in the wind
Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,
Journal changes and initiatives
Presentation transcript:

Surgery for rheumatic tricuspid valve disease: A 30-year experience José M. Bernal, MD, Alejandro Pontón, MD, Begoña Diaz, MD, Javier Llorca, MD, Iván García, MD, Aurelio Sarralde, MD, Carmen Diago, MD, José M. Revuelta, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 136, Issue 2, Pages 476-481 (August 2008) DOI: 10.1016/j.jtcvs.2008.02.065 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival curve for all causes of death (thin solid line) with 95% confidence interval (dashed lines). Thick solid line represents expected survival curve for cohort of Spanish population with same age and sex distribution. Number of patients at risk are displayed every 5 years. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 476-481DOI: (10.1016/j.jtcvs.2008.02.065) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial curve for freedom from reoperation (thick solid line) with 95% confidence interval (dashed lines). Number of patients at risk are displayed every 5 years. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 476-481DOI: (10.1016/j.jtcvs.2008.02.065) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions